The effect of Myo-inositol on pregnancy success
Phase 3
- Conditions
- Female infertility.Female infertility
- Registration Number
- IRCT20181225042109N1
- Lead Sponsor
- Sanandaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
Infertility for at least one year
Not using contraception
Candidates for IVF / ICSI
Minimum age of 20 years and a maximum of 40 years
Agonist cycles
having a regular menstrual cycle (24-35 days)
Exclusion Criteria
Underlying disease
Uterine Anomaly
Freeze embryo transfer cycle
History of repeated abortions
Women with any underlying diseases such as metabolic or endocrine disorders and uterine anomaly
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number and quality of oocytes obtained. Timepoint: Two weeks after the intervention. Method of measurement: Using Sonography.;Number and quality of embryos formed. Timepoint: Third week after intervention. Method of measurement: Using Sonography.
- Secondary Outcome Measures
Name Time Method umber of clinical pregnancy. Timepoint: Clinical pregnancy was defined as a fetal cardiac activity in the 6th to 7th week of pregnancy. Method of measurement: Sonography.;Miscarriage. Timepoint: Pregnancy loss earlier than the 20th week of gestation. Method of measurement: Observation and sonography.;Preterm delivery. Timepoint: It was measured during the pregnancy. Definition: Birth of the baby earlier than 37wk of the pregnancy. Method of measurement: Observation and sonography.;Live birth. Timepoint: At the end of pregnancy. Method of measurement: Observation.